BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36473432)

  • 1. Interference with Lipoprotein Maturation Sensitizes Methicillin-Resistant Staphylococcus aureus to Human Group IIA-Secreted Phospholipase A2 and Daptomycin.
    Kuijk MM; Wu Y; van Hensbergen VP; Shanlitourk G; Payré C; Lambeau G; Man-Bovenkerk S; Herrmann J; Müller R; van Strijp JAG; Pannekoek Y; Touqui L; van Sorge NM
    J Innate Immun; 2023; 15(1):333-350. PubMed ID: 36473432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Streptococcal Lancefield polysaccharides are critical cell wall determinants for human Group IIA secreted phospholipase A2 to exert its bactericidal effects.
    van Hensbergen VP; Movert E; de Maat V; Lüchtenborg C; Le Breton Y; Lambeau G; Payré C; Henningham A; Nizet V; van Strijp JAG; Brügger B; Carlsson F; McIver KS; van Sorge NM
    PLoS Pathog; 2018 Oct; 14(10):e1007348. PubMed ID: 30321240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant
    Taglialegna A; Varela MC; Rosato RR; Rosato AE
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elasnin Effectively Eradicates Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus Biofilms.
    Sulaiman JE; Long L; Qian PY; Lam H
    Microbiol Spectr; 2022 Feb; 10(1):e0232021. PubMed ID: 35196789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Daptomycin Tolerance and Resistance Mutations in Methicillin-Resistant Staphylococcus aureus from Adaptive Laboratory Evolution.
    Sulaiman JE; Lam H
    mSphere; 2021 Oct; 6(5):e0069221. PubMed ID: 34585959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Clinically Selected Staphylococcus aureus
    Xu L; Henriksen C; Mebus V; Guérillot R; Petersen A; Jacques N; Jiang JH; Derks RJE; Sánchez-López E; Giera M; Leeten K; Stinear TP; Oury C; Howden BP; Peleg AY; Frees D
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0032823. PubMed ID: 37184389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activity of daptomycin against VRE and MRSA strains].
    Aktaş G; Derbentli S
    Mikrobiyol Bul; 2014 Jan; 48(1):123-8. PubMed ID: 24506722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and genotypic correlates of daptomycin-resistant methicillin-susceptible Staphylococcus aureus clinical isolates.
    Kang KM; Mishra NN; Park KT; Lee GY; Park YH; Bayer AS; Yang SJ
    J Microbiol; 2017 Feb; 55(2):153-159. PubMed ID: 28120188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations.
    Kanesaka I; Fujisaki S; Aiba Y; Watanabe S; Mikawa T; Katsuse AK; Takahashi H; Cui L; Kobayashi I
    J Infect Chemother; 2019 Jan; 25(1):1-5. PubMed ID: 30322736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus.
    Sakoulas G; Okumura CY; Thienphrapa W; Olson J; Nonejuie P; Dam Q; Dhand A; Pogliano J; Yeaman MR; Hensler ME; Bayer AS; Nizet V
    J Mol Med (Berl); 2014 Feb; 92(2):139-49. PubMed ID: 24297496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin.
    French GL
    J Antimicrob Chemother; 2006 Dec; 58(6):1107-17. PubMed ID: 17040922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging issues on
    García de la Mària C; Cañas MA; Fernández-Pittol M; Dahl A; García-González J; Hernández-Meneses M; Cuervo G; Moreno A; Miró JM; Marco F
    Expert Rev Anti Infect Ther; 2023 Mar; 21(3):281-293. PubMed ID: 36744387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four Novel Leaderless Bacteriocins, Bacin A1, A2, A3, and A4 Exhibit Potent Antimicrobial and Antibiofilm Activities against Methicillin-Resistant Staphylococcus aureus.
    Liu S; Deng S; Liu H; Tang L; Wang M; Xin B; Li F
    Microbiol Spectr; 2022 Oct; 10(5):e0094522. PubMed ID: 36000904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of fosfomycin alone and in combination against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid.
    Saravolatz LD; Pawlak J
    J Antimicrob Chemother; 2022 Dec; 78(1):238-241. PubMed ID: 36374572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.
    Mehta S; Singh C; Plata KB; Chanda PK; Paul A; Riosa S; Rosato RR; Rosato AE
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6192-200. PubMed ID: 22985884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
    J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Clinical Isolates Among Daptomycin-Naive Patients in Korea.
    Nam EY; Yang SJ; Kim ES; Cho JE; Park KH; Jung SI; Yoon N; Kim DM; Lee CS; Jang HC; Park Y; Lee KS; Kwak YG; Lee JH; Park SY; Hwang JH; Kim M; Song KH; Kim HB
    Microb Drug Resist; 2018 Jun; 24(5):534-541. PubMed ID: 29863982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin in bone and joint infections: a review of the literature.
    Rice DA; Mendez-Vigo L
    Arch Orthop Trauma Surg; 2009 Nov; 129(11):1495-504. PubMed ID: 18989686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unstable Mechanisms of Resistance to Inhibitors of Escherichia coli Lipoprotein Signal Peptidase.
    Pantua H; Skippington E; Braun MG; Noland CL; Diao J; Peng Y; Gloor SL; Yan D; Kang J; Katakam AK; Reeder J; Castanedo GM; Garland K; Komuves L; Sagolla M; Austin CD; Murray J; Xu Y; Modrusan Z; Xu M; Hanan EJ; Kapadia SB
    mBio; 2020 Sep; 11(5):. PubMed ID: 32900806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxiconazole Potentiates Gentamicin against Gentamicin-Resistant Staphylococcus aureus
    Kaul G; Akhir A; Shukla M; Shafi H; Akunuri R; Pawar G; Ghouse M; Srinivas N; Chopra S
    Microbiol Spectr; 2023 Aug; 11(4):e0503122. PubMed ID: 37428033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.